Symbol="VIRX"
AssetType="Common Stock"
Name="Viracta Therapeutics Inc"
Description="Viracta Therapeutics, Inc., a precision oncology company, is dedicated to developing drugs for the treatment of virus-associated malignancies. The company is headquartered in Cardiff-by-the-Sea, California."
CIK="1061027"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="395 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="54784000"
EBITDA="-53966000"
PERatio="None"
PEGRatio="None"
BookValue="0.916"
DividendPerShare="0"
DividendYield="0"
EPS="-1.38"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.409"
ReturnOnEquityTTM="-0.896"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.38"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="8.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.182"
EVToRevenue="-"
EVToEBITDA="-0.148"
Beta="-0.174"
num_52WeekHigh="5.75"
num_52WeekLow="0.88"
num_50DayMovingAverage="1.442"
num_200DayMovingAverage="1.715"
SharesOutstanding="38580400"
DividendDate="2020-09-03"
ExDividendDate="None"
symbol="VIRX"
open="1.45"
high="1.49"
low="1.38"
price="1.43"
volume="118576.00"
latest_trading_day="2023-08-24"
previous_close="1.42"
change="0.01"
change_percent="0.7042%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="41"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="59"
Volume_recent_avg="186949"
Change_recent_avg="-0.02"
Delta_recent_avg="0.13"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.24"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="59"
Aroon_momentum_negative="41"
image_negative_thumbnail_id_1="100"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0076.jpeg"
image_negative_thumbnail_id_2="516"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0089.jpeg"
image_neutral_thumbnail_id_1="526"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="626"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0082.jpeg"
image_positive_thumbnail_id_2="679"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0029.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
